Literature DB >> 8991802

Functional role of endothelin ETA and ETB receptors in venous and arterial smooth muscle.

N J Lodge1, R Zhang, N N Halaka, S Moreland.   

Abstract

The functional importance of endothelin ETA and ETB receptors in selected arterial and venous smooth muscle preparations was characterized. Endothelin-1 induced force in the saphenous and jugular veins is normally mediated by endothelin ETB-like receptors. However, desensitization or pharmacological block of these receptors reveals an endothelin ETA receptor population that is of sufficient size to mediate full endothelin-1-evoked force. Block of either endothelin ETA or endothelin ETB receptors alone is insufficient to antagonize endothelin-1-evoked force in saphenous vein. Endothelin-1-induced force in hamster aorta may also be mediated by activation of both endothelin ETA and ETB receptors. However, activation of endothelin ETB-like receptors alone is insufficient to generate a full endothelin-1 response. Sarafotoxin S6c treatment, to desensitize endothelin ETB receptors, failed to affect the responses of rat aorta and rabbit carotid artery to endothelin-1 or endothelin ETA receptor antagonists. These findings indicate that selective endothelin receptor antagonists will vary enormously in their efficacy against endothelin-induced force in different vascular beds.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8991802     DOI: 10.1016/0014-2999(95)00494-7

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  10 in total

1.  Evidence that ET-1, but not ET-3 and S6b, ET(A)-receptor mediated contractions in isolated rat mesenteric arteries are modulated by co-activation of ET(B) receptors.

Authors:  M Adner; N Shankley; L Edvinsson
Journal:  Br J Pharmacol       Date:  2001-07       Impact factor: 8.739

Review 2.  Endothelin receptors: what's new and what do we need to know?

Authors:  Stephanie W Watts
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-11-11       Impact factor: 3.619

3.  MEK1/2 inhibition attenuates vascular ETA and ETB receptor alterations after cerebral ischaemia.

Authors:  Marie Henriksson; Emelie Stenman; Petter Vikman; Lars Edvinsson
Journal:  Exp Brain Res       Date:  2006-11-08       Impact factor: 1.972

4.  Importance of ERK1/2 in upregulation of endothelin type B receptors in cerebral arteries.

Authors:  Marie Henriksson; Cang-Bao Xu; Lars Edvinsson
Journal:  Br J Pharmacol       Date:  2004-07-05       Impact factor: 8.739

5.  Pharmacological endothelin receptor interaction does not occur in veins from ET(B) receptor deficient rats.

Authors:  Keshari Thakali; James J Galligan; Gregory D Fink; Cheryl E Gariepy; Stephanie W Watts
Journal:  Vascul Pharmacol       Date:  2008-04-03       Impact factor: 5.773

6.  Endothelin-1-induced venous contraction is maintained in DOCA-salt hypertension; studies with receptor agonists.

Authors:  Stephanie W Watts; Gregory D Fink; Carrie A Northcott; James J Galligan
Journal:  Br J Pharmacol       Date:  2002-09       Impact factor: 8.739

7.  Protein kinase C inhibition attenuates vascular ETB receptor upregulation and decreases brain damage after cerebral ischemia in rat.

Authors:  Marie Henriksson; Emelie Stenman; Petter Vikman; Lars Edvinsson
Journal:  BMC Neurosci       Date:  2007-01-09       Impact factor: 3.288

8.  Inhibition of PKC activity blocks the increase of ETB receptor expression in cerebral arteries.

Authors:  Marie Henriksson; Petter Vikman; Emelie Stenman; Saema Beg; Lars Edvinsson
Journal:  BMC Pharmacol       Date:  2006-11-28

9.  Increased expression of vascular endothelin type B and angiotensin type 1 receptors in patients with ischemic heart disease.

Authors:  Ivan Dimitrijevic; Marie-Louise Edvinsson; Qingwen Chen; Malin Malmsjö; Per-Ola Kimblad; Lars Edvinsson
Journal:  BMC Cardiovasc Disord       Date:  2009-08-25       Impact factor: 2.298

10.  Up-regulation of endothelin type B receptors in the human internal mammary artery in culture is dependent on protein kinase C and mitogen-activated kinase signaling pathways.

Authors:  David Nilsson; Lotta Gustafsson; Angelica Wackenfors; Bodil Gesslein; Lars Edvinsson; Per Paulsson; Richard Ingemansson; Malin Malmsjö
Journal:  BMC Cardiovasc Disord       Date:  2008-09-08       Impact factor: 2.298

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.